KLK3 and prostate cancer: The demonstration of a certain degree of independence of ‘aspecific’ (PCnano1, PCnano2) exosome descriptors from PSA specific (NSFC-exo) one, points to the fact cancer-healthy discrimination obtained by exosome size and number builds upon biological features not strictly related to prostate cancer specificity and thus could be used for ‘general’ cancer screening.